ID   MM138-2T
AC   CVCL_UM64
DR   Wikidata; Q95990179
RX   PubMed=3756862;
CC   Selected for resistance to: ChEBI; CHEBI_72568; MTIC (5-(3-methyl-1-triazeno)imidazole-4-carboxamide).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2602 ! MM138
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
RX   PubMed=3756862;
RA   Maynard K., Parsons P.G.;
RT   "Cross-sensitivity of methylating agents, hydroxyurea, and
RT   methotrexate in human tumor cells of the Mer- phenotype.";
RL   Cancer Res. 46:5009-5013(1986).
//